Skip to main content
. 2021 Dec 9;16(12):e0261221. doi: 10.1371/journal.pone.0261221

Table 2. Characteristics of confirmed SARS-COV-2 reinfection cases as reported in observational studies analysed.

Author Preprint Country and Setting Total Reinfection cases Age in years Re-positive rate (%) Time in weeks between 1st and 2nd episode Symptomatic at reinfection (%) Onward transmission from 2nd episode
Hanrath AT et al. [67] No UK, healthcare workers 1038 0 NR 0.00% 24 NA NR
Abu-Raddad LJA et al. [63] Yes Qatar, surveillance 133266 54 median 33
range (16–57)
0.04% median 9.3 (6.4–18.4) 42.6% NR
Pilz et al. [25] No Austria, surveillance 14840 40 median 39.8
range (26–55)
0.27% 30±4 7.5% hospitalisation NR
Lumley SF et al. [62] Yes UK, healthcare workers 1246 4 NR 0.32% 22.8–33 25.0% NR
Patwardhan A [68] No USA, children 989 4 median 3.55
range (0.2–13)
0.40% 1–3 after last negative 50.0% NR
Hansen CH et al. [26] No Denmark, surveillance 11068 72 NR 0.65% >12 NR NR
Luo S et al. [81] No China, hospital patients 1673 13 NR 0.78% NR 100% NR
Pan L et al. [73] No China, hospital patients 1350 14 44.4 ± 15 1.04% 1.7 ± 0.7 after discharge 7.1% not found
Kang YJ et al. [82] No South Korea 7829 163 in groups 2.08% >1–5 after discharge 43.9% mild NR
Du HW et al. [74] No China, hospital patients 126 3 NR 2.38% 1–3 after treatment >66.7% not found
Ali AM et al. [61] Yes Iraq, hospital patients 829 26 range 10–60 3.14% 3.7–19.7 after recovery 96.2% NR
Wang X et al. [83] No China, hospital patients 193 12 55.5 ±13.7 6.22% 4–8 83.3% NR
Zhou J et al. [80] No China, hospital patients 368 23 51±16 6.25% 5 82.1% NR
Qiao XM et al. [75] No China, hospital patients 15 1 NR 6.67% 2 100% not found
Hu J et al. [84] No China, hospital patients 117 8 46.25 ± 17.7 6.84% median 1.8 (1.7–2.3) after discharge 100% NR
Tao W et al. [85] No China, hospital patients 173 12 NR 6.94% 5 0% NR
Liu T et al. [86] No China, hospital patients 150 11 median 49
range (37–62)
7.33% 2 NR NR
Chen J et al. [87] No China, hospital patients 1087 81 median 62
range (16–90)
7.45% median 1.3 (0.4–2.6) 84%mild; 16% moderate/severe NR
Zheng J et al. [88] No China, hospital patients 285 27 median 44
range (32–62)
9.47% 1 (0.7–1.1) 37.1% NR
Bongiovanni M et al. [69] No Italy, hospital patients 1146 125 mean 65.7 95%CI (26–95) 10.91% 2.9 (95% CI 0.4–6.1) after discharge 23.2% NR
Zhang K et al. [89] No China, hospital patients 220 27 22–78 12.27% 1–8 22% mild; 77% moderate NR
Tian M et al. [90] No China, hospital patients 147 20 mean 37.2
range (4–80)
13.61% 1–6.7 after discharge 0% NR
Lu J et al. [12] No China, hospital patients 619 87 median 28
range (0.3–69)
14.05% 1 (0.3–2.7) after discharge 0% NR
An J et al. [76] No China, hospital patients 262 38 94.7% < 60y 14.50% 2 29% mild; 71% moderate not found
Yuan J et al. [91] No China, hospital patients 172 25 median 28
range 16.3–42
14.53% 1 week ± 0.55 after last negative 32% mild NR
Wu J et al. [92] No China, hospital patients 60 10 NR 16.67% 1–8 20% mild NR
Yang C et al. [72] No China, hospital patients 479 93 median 34 95%CI (29–38) 19.42% 2–6 28% mild not found
Abdullah MS et al. [77] No China, hospital patients 138 27 41.3 ± 17.0  19.57% 1.5 after discharge 22% mild not found
Wong J et al. [78] No Brunei, hospital patients 106 21 median 47 19.81% 3–5 5% not found
Xiao AT [64] Yes China, hospital patients 70 15 median 64
range (51–73)
21.43% 3–7 NR NR
Li Y et al. [71] No China, hospital patients 13 4 median 37
range (1–73)
30.77% 0.7–2 after discharge 100% NR
Zhang X et al. [93] No China, hospital patients 59 19 NR 32.20% NR 0% NR
Peng D et al. [70] No China, hospital patients 38 14 7.2±4.8 36.84% 1–5 71.4% not found
Zhao W et al. [66] No China, hospital patients 14 7 median 5.7
range (3–7)
50.00% median 2 (1–2.4) after discharge 14.3% NR
Chen LZ et al. [65] No China, hospital patients NA 44 49.68 ± 16.80 NA 2 after discharge >63.6% NR

NR not reported, CI confidence interval.